Carvedilol Phosphate
12 NDCs across 3 manufacturers|12 Generic,0 Brand
Carvedilol Phosphate is used to treat angina pectoris, heart failure, hypertension and myocardial infarction, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Oct 20, 2006, and the first generic was approved Oct 25, 2017. FDA's Orange Book lists 12 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $41 million on Carvedilol Phosphate across 90,000 claims for 22,000 beneficiaries.
Carvedilol Phosphate is available as 12 NDCs from 3 manufacturers (12 generic, 0 brand), with NADAC prices from $5.71 to $6.56 per EA — a 15% difference between cheapest and most expensive. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
12
12G / 0B
Manufacturers
3
competing in market
Price Spread
$5.71 – $6.56
per EA
7d Activity
avg -1.3% WoW · of 12 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Manufacturer Breakdown
3 manufacturers producing CARVEDILOL PHOSPHATE
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
CARVEDILOL ER 20 MG CAPSULE | $6.5631 per EA | +0.27% |
CARVEDILOL ER 20 MG CAPSULE | $6.5631 per EA | +0.27% |
CARVEDILOL ER 20 MG CAPSULE | $6.5631 per EA | +0.27% |
CARVEDILOL ER 40 MG CAPSULE | $6.4442 per EA | -3.57% |
CARVEDILOL ER 40 MG CAPSULE | $6.4442 per EA | -3.57% |
CARVEDILOL ER 40 MG CAPSULE | $6.4442 per EA | -3.57% |
CARVEDILOL ER 10 MG CAPSULE | $6.3861 per EA | -2.48% |
CARVEDILOL ER 10 MG CAPSULE | $6.3861 per EA | -2.48% |
CARVEDILOL ER 10 MG CAPSULE | $6.3861 per EA | -2.48% |
CARVEDILOL ER 80 MG CAPSULE | $5.7064 per EA | +0.79% |
CARVEDILOL ER 80 MG CAPSULE | $5.7064 per EA | +0.79% |
CARVEDILOL ER 80 MG CAPSULE | $5.7064 per EA | +0.79% |
Frequently Asked Questions
What is Carvedilol Phosphate used to treat?
Carvedilol Phosphate is used to treat angina pectoris, heart failure, hypertension and myocardial infarction, per the National Library of Medicine's MED-RT classification.
When did Carvedilol Phosphate become available as a generic?
FDA approved the first generic Carvedilol Phosphate (ANDA) on Oct 25, 2017. The Orange Book currently lists 12 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Carvedilol Phosphate?
In 2024, Medicare Part D spent $41 million on Carvedilol Phosphate across 90,000 claims for 22,000 beneficiaries.
How many Carvedilol Phosphate products are on the market?
The Carvedilol Phosphate drug market contains 12 NDCs from 3 manufacturers — 12 generic and 0 brand products.
What is the price range for Carvedilol Phosphate?
NADAC reference prices for Carvedilol Phosphate range from $5.7064 to $6.5631 per EA — a 15% difference between cheapest and most expensive.
Which manufacturers make Carvedilol Phosphate?
3 manufacturers list Carvedilol Phosphate in NADAC. Ranked by number of NDCs, the largest are Sun Pharmaceutical Industries Inc. (4), Amneal Pharmaceuticals of New York LLC (4), NorthStar Rx LLC (4).
How has the price of Carvedilol Phosphate changed recently?
Over the past 7 days, 12 Carvedilol Phosphate NDCs rose and 12 fell, with a market-wide average change of -1.3%.